| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 1.630 | 25.098 | 57.354 |
| Total Income - EUR | - | - | - | - | - | - | - | 1.630 | 26.127 | 71.387 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 439 | 3.537 | 34.112 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 1.191 | 22.590 | 37.275 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 1.142 | 19.286 | 35.629 |
| Employees | - | - | - | - | - | - | - | 0 | 1 | 2 |
Check the financial reports for the company - Andramed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 65.701 | 52.170 |
| Current Assets | - | - | - | - | - | - | - | 1.637 | 83.100 | 33.411 |
| Inventories | - | - | - | - | - | - | - | 0 | 2 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 40.432 | 0 |
| Cash | - | - | - | - | - | - | - | 1.637 | 42.666 | 33.411 |
| Shareholders Funds | - | - | - | - | - | - | - | 1.182 | 19.326 | 35.678 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 454 | 89.042 | 23.343 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 40.432 | 26.561 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Andramed S.r.l.